Cleared Traditional

K120855 - INTELLISPACE ECG

K120855 is an FDA 510(k) clearance for INTELLISPACE ECG, manufactured by Philips Health Care. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 100-day FDA review.

K120855 · Philips Health Care · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
100d
Days
Class 2
Risk

K120855 is an FDA 510(k) clearance for the INTELLISPACE ECG. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Philips Health Care (Thousand Oaks, US). The FDA issued a Cleared decision on June 29, 2012 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Health Care devices

FDA 510(k) Submission Details - K120855

510(k) Number K120855 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 21, 2012
Decision Date June 29, 2012
Days to Decision 100 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
25d faster than avg
Panel avg: 125d · This submission: 100d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 358
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K120855.
MUSE CARDIOLOGY INFORMATION SYSTEM
K130155 · Ge Medical Systems Information Technologies, Inc. · Mar 2013
HEALTHVIEW ECG MANAGER
K123466 · Lumedx · Dec 2012
ST80I STRESS TEST SYSTEM
K121638 · Philips Health Care · Jul 2012
CARTO(R) EP NAVIGATION SYSTEM, VERSION 3.0 (WITH STANDARD LOCATION PAD)
K120550 · Biosense Webster, Inc. · May 2012
HORIZON CARDIOLOGY ECG MANAGEMENT
K113515 · Mckesson Israel , Ltd. · Mar 2012
V2.6 SOFTWARE FOR THE LABSYSTEM PRO EP RECORDING SYSTEM
K113811 · C.R. Bard Inc., Bard Electrophysiology Division · Mar 2012